Mind Medicine (MindMed) Inc. Income Statement
DFTX / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.70 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| SG&A Expense | $48.6M | $38.6M | $41.7M | $30.2M | $59.1M | $14.4M | $3.2M |
| R&D Expense | $117.7M | $65.3M | $52.1M | $36.2M | $34.8M | $18.6M | $7.5M |
| Operating Income | -$166.3M | -$103.9M | -$93.9M | -$66.3M | -$93.9M | -$33.0M | -$10.7M |
| Interest Expense | $5.5M | $2.3M | $920.0K | $1.5M | -$359.0K | -$164.0K | $10.0K |
| Income Tax | $0 | - | - | - | -$1.2M | - | - |
| Net Income | -$183.8M | -$108.7M | -$95.7M | -$56.8M | -$93.0M | -$33.9M | -$10.7M |
| EPS (Basic) | -$2.06 | -$1.54 | -$2.44 | -$1.84 | -$3.40 | - | - |
| EPS (Diluted) | -$2.06 | -$1.54 | -$2.44 | -$1.84 | -$3.40 | - | - |
| Shares Outstanding | 89.3M | 70.5M | 39.2M | 30.9M | 27.4M | 266.2M | 102.8M |